Peg ‐interferon and ribavirin treatment in HIV/HCV co‐infected patients in Thailand: efficacy, safety, and pharmacokinetics

ConclusionsPR treatment has comparable response rates and toxicity profile in Thai HIV/HCV co‐infected patients as in Western HIV/HCV patients. However, ribavirin plasma concentrations were comparable with previously published studies in HIV/HCV co‐infected patients, but both, just as SVR‐rate, were lower than in mono‐infected patients.This article is protected by copyright. All rights reserved.

Source: Tropical Medicine and International Health - December 1, 2017 Category: Tropical Medicine Authors: E. J Smolders, N Thammajaruk, C. T. M. M de Kanter, A. Colbers, P. Chaiyahong, T. Cuprasitrut, S. Chittmittraprap, T. Apornpong, S. Khemnark, P. Tangkijvanich, D. M. Burger, A. Avihingsanon, Tags: Original Article Source Type: research